Highlights
- Market Cap
- $1.53B
- Enterprise Value
- $3.15B
- EPS (TTM)
- $3.33
- PE Ratio
- 5.31
- PEG Ratio
- 0.05
- Total Revenue (TTM)
- $1.91B
- Gross Profit (TTM)
- $1.10B
- EBITDA (TTM)
- $577.07M
- Year Range
- $16.56 - $22.35
- ROA (TTM)
- 5.87%
- ROE (TTM)
- 11.30%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in United States Cellular Corporat, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
United States Cellular Corporat (UZE) has returned 1.20% so far this year and -13.76% over the past 12 months.
United States Cellular Corporat
- 1D
- 0.06%
- 1M
- -5.70%
- YTD
- 1.20%
- 6M
- -0.13%
- 1Y
- -13.76%
- 3Y*
- 9.48%
- 5Y*
- -0.26%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Dec 15, 2020, UZE's average daily return is +0.01%, while the average monthly return is +0.32%. At this rate, your investment would double in approximately 18.1 years.
Historically, 53% of months were positive and 47% were negative. The best month was Jan 2023 with a return of +27.8%, while the worst month was Aug 2025 at -19.5%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 5 months.
On a daily basis, UZE closed higher 48% of trading days. The best single day was May 28, 2024 with a return of +18.1%, while the worst single day was Aug 11, 2025 at -7.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 2.70% | 4.51% | -5.70% | 1.20% | |||||||||
| 2025 | -1.03% | 1.19% | 0.00% | -0.50% | 2.33% | -7.23% | 8.04% | -19.47% | 5.08% | -1.90% | 1.27% | -0.67% | -14.66% |
| 2024 | 3.70% | 5.37% | -5.85% | -1.39% | 22.05% | -4.64% | 0.25% | 4.65% | 6.05% | 1.12% | 2.41% | -1.50% | 33.98% |
| 2023 | 27.75% | -9.25% | 1.88% | -9.94% | -3.14% | 2.10% | -1.16% | 25.28% | -7.06% | -9.72% | 18.77% | 3.18% | 33.94% |
| 2022 | -5.42% | -5.15% | -3.85% | -10.56% | 5.05% | -10.51% | 12.55% | -3.93% | -6.23% | -7.73% | -1.36% | -11.89% | -41.03% |
| 2021 | -0.16% | -1.35% | 4.00% | 0.39% | 1.33% | 2.42% | 0.61% | 0.76% | 0.92% | 0.64% | -2.68% | 3.33% | 10.50% |
Benchmark Metrics
United States Cellular Corporat has an annualized alpha of -2.14%, beta of 0.44, and R² of 0.09 versus S&P 500 Index. Calculated based on daily prices since December 16, 2020.
- This stock participated in 79.75% of S&P 500 Index downside but only 41.39% of its upside — more exposed to losses than it benefited from rallies.
- Beta of 0.44 may look defensive, but with R² of 0.09 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R² of 0.09 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -2.14%
- Beta
- 0.44
- R²
- 0.09
- Upside Capture
- 41.39%
- Downside Capture
- 79.75%
Return for Risk
Risk / Return Rank
UZE ranks 16 for risk / return — in the bottom 16% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for United States Cellular Corporat (UZE) and compare them to a chosen benchmark (S&P 500 Index).
| UZE | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.71 | 0.90 | -1.61 |
Sortino ratioReturn per unit of downside risk | -0.82 | 1.39 | -2.20 |
Omega ratioGain probability vs. loss probability | 0.88 | 1.21 | -0.34 |
Calmar ratioReturn relative to maximum drawdown | -0.56 | 1.40 | -1.96 |
Martin ratioReturn relative to average drawdown | -1.07 | 6.61 | -7.68 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore UZE risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
United States Cellular Corporat provided a 7.77% dividend yield over the last twelve months, with an annual payout of $1.38 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Dividend | $1.38 | $1.38 | $1.38 | $1.38 | $1.37 | $1.37 |
Dividend yield | 7.77% | 7.72% | 6.14% | 7.71% | 9.44% | 5.19% |
Monthly Dividends
The table displays the monthly dividend distributions for United States Cellular Corporat. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.34 | $0.00 | $0.34 | |||||||||
| 2025 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $1.38 |
| 2024 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $1.38 |
| 2023 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $1.38 |
| 2022 | $0.00 | $0.34 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.34 | $0.00 | $0.00 | $0.34 | $0.00 | $1.37 |
| 2021 | $0.33 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.34 | $0.00 | $1.37 |
Dividend Yield & Payout
Dividend Yield
United States Cellular Corporat has a dividend yield of 7.77%, which means its dividend payment is significantly above the market average.
Payout Ratio
United States Cellular Corporat has a payout ratio of 684.66%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the United States Cellular Corporat. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the United States Cellular Corporat was 48.42%, occurring on May 16, 2023. Recovery took 338 trading sessions.
The current United States Cellular Corporat drawdown is 15.49%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -48.42% | Sep 23, 2021 | 414 | May 16, 2023 | 338 | Sep 19, 2024 | 752 |
| -24.09% | Aug 1, 2025 | 14 | Aug 20, 2025 | — | — | — |
| -9.95% | Dec 4, 2024 | 84 | Apr 7, 2025 | 79 | Jul 31, 2025 | 163 |
| -3.14% | Dec 21, 2020 | 14 | Jan 11, 2021 | 55 | Mar 31, 2021 | 69 |
| -3.13% | May 10, 2021 | 3 | May 12, 2021 | 11 | May 27, 2021 | 14 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of United States Cellular Corporat over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how United States Cellular Corporat is priced in the market compared to other companies in the undefined industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for UZE, comparing it with other companies in the undefined industry. Currently, UZE has a P/E ratio of 5.3. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for UZE compared to other companies in the undefined industry. UZE currently has a PEG ratio of 0.1. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for UZE relative to other companies in the undefined industry. Currently, UZE has a P/S ratio of 0.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for UZE in comparison with other companies in the undefined industry. Currently, UZE has a P/B value of 0.6. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |